Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.6000
+0.0150 (2.56%)
Jun 19, 2026, 4:10 PM AEST
Alterity Therapeutics Employees
Alterity Therapeutics had 9 employees as of June 30, 2025. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
737.38K AUD
Profits / Employee
-1.62M AUD
Market Cap
130.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 9 | -1 | -10.00% |
| Jun 30, 2024 | 10 | -1 | -9.09% |
| Jun 30, 2023 | 11 | -1 | -8.33% |
| Jun 30, 2022 | 12 | 1 | 9.09% |
| Jun 30, 2021 | 11 | -1 | -8.33% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Alterity Therapeutics News
- 3 days ago - Alterity Therapeutics assumed with a Buy at Ladenburg - TheFly
- 4 days ago - Alterity Therapeutics Slides: Corporate presentation - Filings
- 9 days ago - Alterity Aligns With FDA On Phase 3 Design For ATH434 In Treating Multiple System Atrophy - Nasdaq
- 10 days ago - Alterity Therapeutics (ATHE) Gets FDA Nod for Phase 3 Program - GuruFocus
- 10 days ago - Alterity Therapeutics (ATHE) Secures FDA Agreement for Phase 3 ATH434 Trial - GuruFocus
- 10 days ago - Alterity Therapeutics achieves alignment with FDA on program for ATH434 in MSA - TheFly
- 10 days ago - Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy - GlobeNewsWire
- 16 days ago - Alterity Therapeutics management to meet with BTIG - TheFly